ENSAYO MULTICENTRICO, ALEATORIZADO, DOBLE CIEGO, COMPARADO CON PLACEBO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DEL TRATAMIENTO CON UN INHIBIDOR DE LA QUIMASA (BAY 1142524), A UNA DOSIS ORAL DE 25 MG BID DURANTE 6 MESES ANADIDO AL TRATAMIENTO ESTANDAR EN PACIENTES CON INFARTO AGUDO DE MIOCARDIO Y REDUCCION DE LA FRACCION DE EYECCION DEL VENTRICULO IZQUIERDO (FEVI . 45%). (CHIARA MIA 2).

Article. 10.1007/s40292-021-00476-4. 2021

Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

De Luca, Giuseppe; (...); Verdoia, Monica

Article. 10.3390/jcm12062116. 2023

Alterations in the Nucleocytoplasmic Transport in Heart Transplant Rejection.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.09.003. 2021

An Unusual Cause of ST-Segment Elevation Myocardial Infarction

Ferré Vallverdú M; (...); Díez Gil JL

Editorial Material. 10.1016/j.jcin.2017.02.031. 2017

Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia, X; (...); Tort, M

Article. 10.7399/fh.11147. 2019

Analysis of complications in patients with ECMO as a bridge to transplantation since the beginning of the technique (2007-2023)

Guerrero Cervera, Borja; (...); Almenar Bonet, Luis

Meeting Abstract. 2024

Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021

Analysis of Heart Transplant Survival According to Difference in Age Between Donor and Recipient.

Article. 10.1016/j.transproceed.2022.10.014. 2022

Analysis of heart transplantation survival according to difference in age between donor and recipient

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Analysis of hospital mortality and primary graft dysfunction in urgent heart transplantation according to the type and duration of circulatory/ventricular assistance

Meeting Abstract. 2017

Analysis of the implantation of heart failure with reduced ejection fraction treatment in clinical practice and its impact on achieving target doses

Esteban Fernandez, A. Alberto; (...); Fernandez, V. Alonso

Meeting Abstract. 2023

Annual evolution of the prescription of drugs with prognostic implications in acute decompensated heart failure with reduced ejection fraction.

Article. 10.1186/s12872-024-03728-y. 2024

Anthracycline mediated cardiotoxicity: Detection of miRNA based early biomarkers for the prediction of myocardial injury. Hecatos study

Coloma, C. Salvador; (...); Santaballa, A.

Meeting Abstract. 10.1093/annonc/mdw365.69. 2016

Antimicrobial stewardship programme implementation in a medical ward

Ruiz, J; (...); Poveda, JL

Article. 2018

Antimicrobial stewardship programme in critical care medicine: A prospective interventional study

Ruiz, J; (...); Catellanos, A

Article. 10.1016/j.medin.2017.07.002. 2018

Arthritis, Pulmonary Cysts and Renal Insufficiency: COPA Syndrome.

Balaguer Cartagena MN, Fonfría Esparcia C, Anguera de Francisco G

Article. 10.1016/j.arbres.2024.04.005. 2024

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023

Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin

Rodriguez-Veiga, R; (...); spanish PETHEMA group

Article. 10.1007/s00277-017-3004-z. 2017

Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Hochman, JS; (...); ISCHEMIA Res Grp

Article. 10.1001/jamacardio.2019.0014. 2019

Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018

Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Article. 10.1016/j.thromres.2018.12.027. 2019

Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project

Pose, A; (...); Manito, N

Article. 10.1002/ehf2.12124. 2017

Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022

BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population

Perez-Huertas, P; (...); Poveda-Andres, JL

Article. 10.1177/1043454216631952. 2017

Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience

Garcia-Robles, AA; (...); Fernandez-Navarro, JM

Meeting Abstract. 2017

Bridge to cardiac transplantation with temporary mechanical circulatory support: trends and outcomes in Spain (2010-2020)

Barge Caballero, E. Eduardo; (...); Crespo-Leiro, M.

Meeting Abstract. 2022

Can the number of Comorbidities predict readmissions for Heart Failure patients?

Ferre, MFM; (...); Almenar, L

Meeting Abstract. 2018

Can we start quadruple therapy in new-diagnosed heart failure patients in real life? Insights into the basal characteristics of TIDY-HF register

Esteban Fernandez, A.; (...); Torres Lego, J.

Meeting Abstract. 2022

Carbohydrate antigen 125 and glutamic oxaloacetic transaminase as congestion markers in acute heart failure. Is there clinical association between them?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.3390/jpm12060913. 2022

Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial.

Sidhu, Mandeep S.; (...); ISCHEMIA Research Group

Article. 10.1016/j.ahj.2022.01.017. 2022

Circulating biomarkers for the detection of the pre-capillary component in patients with pulmonary hypertension due to left heart diseases

Ferrer, JLM; (...); Bonet, LA

Meeting Abstract. 2017

Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation.

Benito-González T; (...); Fernández-Vázquez F

Article. 10.1016/j.ijcard.2021.09.056. 2021

Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Article. 10.1016/j.thromres.2021.07.009. 2021

Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy

Hamadeh, A; (...); McCullough, P

Meeting Abstract. 2020

Clinical outcomes of temporary mechanical circulatory support as a bridge to heart transplantation in Spain: a nationwide registry.

Caballero, EEB; (...); Mirabet-Perez, S

Meeting Abstract. 2017

Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry

Barge-Caballero, E; (...); Crespo-Leiro, MG

Article. 10.1002/ejhf.956. 2018

Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019

Clinical phenotypes according to diuretic combination in acute heart failure.

Article. 10.1016/j.hjc.2023.03.009. 2023

Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial

Esteban-Fernandez, Alberto; (...); VERISEC Registry Researchers

Article. 10.3389/fcvm.2024.1504427. 2025

Clinical profile of heart failure patients starting vericiguat in clinical practice

Esteban Fernandez, A. Alberto; (...); Diez Villanueva, P.

Meeting Abstract. 2024

Clinical profiling of patients admitted with acute heart failure: a comprehensive survival analysis.

Article. 10.3389/fcvm.2024.1381514. 2024

Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry.

Alonso Salinas, Gonzalo Luis; (...); Diez-Villanueva, Pablo

Article. 10.1002/ehf2.15260. 2025

Clinical Utility of the IMPACT Score for Mortality Prediction after Heart Transplantation: External Validation Study

Bautista, CDO; (...); Jimenez, JFD

Meeting Abstract. 10.1016/j.healun.2019.01.517. 2019

Clinical, echocardiographic and analytical patterns of biomarkers in cardiac amyloidosis; a real-world analysis.

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2024

Cold ischemia >4 hours increases heart transplantation mortality. An analysis of the Spanish heart transplantation registry

Valero-Masa, MJ; (...); Martinez-Selles, M

Article. 10.1016/j.ijcard.2020.06.009. 2020

Collaborative model of home delivery program in haemophilia through an association of patients

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018

COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021

Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time

Article. 10.3390/biomedicines12092109. 2024

Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Meeting Abstract. 2020

Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction.

Biscaglia S; (...); Campo G

Article. 10.1056/NEJMoa2300468. 2023

Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial.

Erriquez, Andrea; (...); Biscaglia, Simone

Article. 10.1001/jamacardio.2024.0804. 2024

Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction With or Without ST-Segment Elevation.

Cocco, Marta; (...); Biscaglia, Simone

Article. 10.1016/j.jacc.2024.07.028. 2024

Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.08.040. 2021

Comprehensive survival analysis in acute heart failure: profiling patients through clinical examination at admission

Raquel Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2024

Consensus document for anaesthesiologist-assisted sedation in interventional cardiology procedures

Martinez-Dolz, L; (...); Alvarez, J

Article. 10.1016/j.redar.2021.01.001. 2021

Consensus on the management of hyperkalemia in patients with heart failure: recommendations from the SEC-SEMI

Bonet, L. Almenar, Gonzalez-Franco, A.

Article. 10.1016/j.rce.2020.11.009. 2022

Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMI.

Almenar Bonet, L, Gonzalez-Franco, A

Article. 10.1016/j.rceng.2020.11.012. 2021

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak.

Moreno R; (...); Paredes E

Article. 10.1002/ccd.29433. 2021

Conversion From Immediate-Release Tacrolimus to Prolonged-Release Tacrolimus in Stable Heart Transplant Patients: A Retrospective Study

Gonzalez-Vilchez, F; (...); Crespo-Leiro, MG

Article. 10.1016/j.transproceed.2019.04.028. 2019

Coronary physiology at the cath lab

Vilchez-Tschischke, Jean Paul; (...); Garcia-Garcia, Hector M.

Review. 10.24875/RECICE.M22000328. 2022

Coronary plaque modification and impact on the microcirculation territory after drug-coated balloon angioplasty: the PLAMI study.

Antonio Sorolla Romero J; (...); Sánchez JS

Article. 10.1016/j.rec.2024.10.001. 2024

Correlates of musculoskeletal pain and kinesiophobia in older adults with heart failure: A structural equation model.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1016/j.gerinurse.2023.07.003. 2023

Correlation of various molecules involved in cellular traffic with the severity of heart failure in patients undergoing cardiac transplantation

Ezzitouny, M.; (...); Martinez-Dolz, L.

Meeting Abstract. 2018

COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024

Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1080/13696998.2017.1311903. 2017

Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020

COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN

Trillo, JL; (...); Torres, C

Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018

COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020

Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021

COVID-19 AND CARDIAC TRANSPLANTATION. EXPERIENCE IN A TERTIARY HOSPITAL

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021

COVID-19 and Heart Transplantation. Initial Experience in a Tertiary Hospital.

Article. 10.1016/j.transproceed.2021.07.054. 2021

COVID-19 infection in heart transplants in pre- and post-vaccination periods

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

COVID-19 Infection in Heart Transplants in Pre- and Postvaccination Periods.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.005. 2022

COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction.

De Luca G; (...); Collaborators

Article. 10.1136/heartjnl-2021-319750. 2022

Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure.

Article. 10.1080/00015385.2020.1871264. 2021

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Letter. 10.1111/hae.13733. 2019

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019

Culprit-Lesion Drug-Coated-Balloon Percutaneous Coronary Intervention in Patients Presenting with ST-Elevation Myocardial Infarction (STEMI)

Sanz-Sanchez, Jorge; (...); Santos, Ignacio Amat

Article. 10.3390/jcm14030869. 2025

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Article. 2022

CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN

Lopez-Vilella, R; (...); Almenar-Bonet, L

Meeting Abstract. 2021

Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024

Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON)

Beltran, IIC; (...); Nunez, J

Meeting Abstract. 2018

Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design

Minana, G; (...); Myocardial-IRON Investigators

Article. 10.1002/clc.22956. 2018

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study

Escribano-Subias, P; (...); Barbera, JA

Article. 10.1186/s12890-020-01197-5. 2020

Changes in the Treatment of Decompensated Advanced Heart Failure During Hospitalization and at Discharge.

Article. 10.1016/j.transproceed.2022.10.002. 2022

Changes in the treatment strategy following intracoronary pressure wire in a contemporaneous real-life cohort of patients with intermediate coronary stenosis. Results from a nationwide registry.

Rodriguez-Leor, Oriol; (...); Perez de Prado, Armando

Article. 10.1016/j.carrev.2023.01.027. 2023

Changes over the years in the indication for heart-lung transplantation in Spain

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction

Hamadeh A; (...); McCullough PA

Article. 10.1016/j.amjcard.2020.06.063. 2020

Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019

De una asistencia biventricular mínimamente invasiva al implante de Heartware.

Pérez-Guillén M; (...); Torregrosa-Puerta S

Article. 10.24875/ACM.21000073. 2022

Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project

Blade, J; (...); Lizan, L

Article. 10.1136/bmjopen-2017-018850. 2018

Defining Severe Secondary Antibody Deficiency in Heart and Lung Transplantation

Carbone, J; (...); Sarmiento, E

Meeting Abstract. 10.1016/j.healun.2018.01.379. 2018

Depression mediates physical activity readiness and physical activity in patients with heart failure

Deka, Pallav; (...); Marques-Sule, Elena

Article. 10.1002/ehf2.13609. 2021

Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021

Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries

Dobarro, David; (...); Gonzalez-Costello, Jose

Article. 10.3390/life14121570. 2024

Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019

DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019

Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019

Development of severity and mortality prediction models for covid-19 patients at emergency department including the chest x-ray

Calvillo-Batllés P; (...); Martí-Bonmatí L

Article. 10.1016/j.rx.2021.09.011. 2022

Development of severity and mortality prediction models for covid-19 patients at emergency department including the chest x-ray.

Calvillo-Batllés P; (...); Martí-Bonmatí L

Article. 10.1016/j.rxeng.2021.09.004. 2022

Diffusion tensor imaging as a prognostic biomarker for motor recovery and rehabilitation after stroke

Puig, J; (...); Pedraza, S

Review. 10.1007/s00234-017-1816-0. 2017

Does fractional flow reserve impact on clinical outcomes by reducing number of stents and contrast media? Findings from a systematic review (N = 56,185) and meta-analysis.

Teira Calderón A; (...); Garcia-Garcia HM

Letter. 10.1016/j.carrev.2023.12.010. 2024

Does the age of the recipient influence the survival of the heart transplant?

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019

Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR).

Jimenez-Blanco, Marta; (...); Segovia-Cubero, Javier

Article. 10.1016/j.healun.2024.11.009. 2024

Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study)

Bravo, M. Jimenez -Blanco; (...); Segovia-Cubero, J.

Meeting Abstract. 2023

Donor-Derived Cell-Free DNA Correlates Well with NT-ProBNP in Heart Transplant Recipients Undergoing Routine Endomyocardial Biopsies During First Year Post-Heart Transplant

Bravo, M. Jimenez-Blanco; (...); Segovia-Cubero, J.

Meeting Abstract. 2023

Donor-Transmitted Coronary Artery Disease in Heart Transplantation: Prevalence and Characteristics in the Real World. Results from the Multicentric Donor Coronary Artery Disease (DONOR-CAD) Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2022

Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry.

Gomez-Bueno, Manuel; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2022.07.011. 2022

Early detection of chemotherapy-induced cardiotoxicity in breast cancer patients

Salvador-Coloma, C; (...); Santaballa, A

Meeting Abstract. 2018

Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases

Review. 10.1007/s10072-017-2833-9. 2017

Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Ribera, E; (...); Hernandez-Novoa, B

Article. 10.1016/j.eimc.2016.11.015. 2018

Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020

Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021

Effects of COVID-19 Lockdown on Heart Failure Patients: A Quasi-Experimental Study.

Sánchez-González JL; (...); Marques-Sule E

Article. 10.3390/jcm12227090. 2023

Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation.

Gonzalez-Vilchez, F; (...); de Prada, JAV

Article. 10.1016/j.rec.2017.03.014. 2018

Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial

Comin-Colet, J; (...); LION-HEART Study Investigators

Article. 10.1002/ejhf.1145. 2018

eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Megias-Vericat, JE

Meeting Abstract. 2018

EPIDEMIOLOGICAL STUDY OF TRICUSPID REGURGITATION AFTER CARDIAC TRANSPLANTATION. DOES IT INFLUENCE SURVIVAL?

Lopez-Vilella, R; (...); Almenar-Bonet, L

Meeting Abstract. 2021

Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?

Article. 10.3389/ti.2022.10197. 2022

EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019

Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study

Sarmiento, E; (...); Carbone, J

Article. 10.1016/j.healun.2016.10.004. 2017

Evolutionary description of heart transplantation and heart-lung transplantation in congenital heart disease

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Evolutionary Description of Heart Transplantation and Heart-Lung Transplantation in Congenital Heart Disease.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.006. 2022

Evolving Indications for Heart-Lung Transplant in Spain.

Article. 10.1016/j.transproceed.2022.10.003. 2022

Experience of Home Delivery Program in Haemophilia Through an Association of Patients

Megias Vericat, J. E.; (...); Bonanad Boix, S.

Meeting Abstract. 2017

Experience with COVID-19 heart transplant patients in a tertiary hospital

Donoso, V.; (...); Almenar Bonet, L.

Article. 2021

Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life

Esteban-Fernandez, Alberto; (...); Lopez-Vilella, Raquel

Article. 10.1002/ehf2.13976. 2022

Exploratory analysis for the implementation of antineoplastic logarithmic dose banding

Albert-Mari, A; (...); Poveda-Andres, JL

Article. 10.1007/s11096-018-0714-9. 2018

EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019

Facilitators and barriers to perform physical activity in patients post-heart transplantation: a qualitative study.

Klompstra L; (...); Marques-Sule E

Article. 10.1093/eurjcn/zvae144. 2024

Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

Beltran, B; (...); Nos, P

Article. 10.1159/000492626. 2019

Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021

Fractional flow reserve use in coronary artery revascularization: A systematic review and meta-analysis.

Sanz Sanchez, Jorge; (...); Garcia-Garcia, Hector M.

Article. 10.1016/j.isci.2023.107245. 2023

Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

De Luca, Giuseppe; (...); Verdoia, Monica

Article. 10.3390/jcm12030896. 2023

Gender Differences in Health-Related Quality of Life in Patients with Systolic Heart Failure: Results of the VIDA Multicenter Study

Garay, A; (...); VIDA-IC Multicenter Study Investig

Article. 10.3390/jcm9092825. 2020

Gender differences in heart transplantation: Twenty-five year trends in the nationwide Spanish heart transplant registry.

García-Cosío MD; (...); Delgado-Jiménez JF

Article. 10.1111/ctr.14096. 2020

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

Giant Circumflex Aneurysm with Arteriovenous Fistula Surgery Guided by Three-dimensional Printing.

Blanco-Herrera OR; (...); Montero-Argudo JA

Editorial Material. 10.1016/j.athoracsur.2019.11.051. 2020

Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022

Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12568. 2017

Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units

Article. 10.7399/fh.10935. 2018

Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022

Heart failure patients with reduced left ventricular ejection fraction, who reached 100% target dose of beta-blockers in randomized and observational studies

Artola, MJMJO; (...); Esteban, A

Meeting Abstract. 2018

Heart transplantation and heart-lung transplantation in congenital heart disease. experience in a tertiary referral hospital

Donoso, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2021

High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022

High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke

Puig, J; (...); Castellanos, M

Article. 10.1371/journal.pone.0188238. 2017

Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022

Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021

How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022

How much does right ventricular dysfunction influence the elevation of NT-proBNP in patients with acute heart failure?

Meeting Abstract. 2018

Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry.

Crespo-Leiro, Maria G.; (...); Delgado-Jimenez, Juan

Article. 10.1016/j.recesp.2019.05.004. 2020

Hypertonic saline solution with furosemide for the treatment of congestive symptoms of acute heart failure

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Hyponatraemia and congestive heart failure refractory to diuretic treatment. Utility of tolvaptan

Pose, A; (...); Manito, N

Article. 10.1016/j.rce.2017.02.013. 2017

Idarucizumab in High-risk Thoracic Surgery

Lopez-Vilella, R; (...); Almenar-Bonet, L

Article. 2018

Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2016.1231405. 2017

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis

Edo Solsona MD; (...); Poveda Andrés JL

Article. 10.2147/PPA.S127508. 2017

Impact of an antimicrobial stewardship program on critical haematological patients.

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.7399/fh.2017.41.4.10709. 2017

Impact of Circulatory Assistance in the Early Evolution After Heart Transplantation. Unicentric Experience.

Martinez-Lauwers, Ana; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.08.041. 2021

Impact of circulatory assistance in the early evolution after heart transplantation: unicentric experience.

Martinez-Lauwers, A.; (...); Martinez-Dolz, L.

Meeting Abstract. 2020

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020

Impact of comorbidities in outpatients with chronic heart failure

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry.

De Luca G; (...); Verdoia M

Article. 10.1186/s12933-020-01196-0. 2020

Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI.

De Luca G; (...); Dudek D

Article. 10.1016/j.jacc.2020.09.546. 2020

Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry

De Luca, Giuseppe; (...); Verdoia, Monica

Article. 10.1186/s12931-022-02128-0. 2022

Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

Moreno, R; (...); Paredes, E

Article. 10.1186/s12933-021-01261-2. 2021

Impact of diabetes on epicardial reperfusion and mortality in a contemporary STEMI population undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry.

De Luca, Giuseppe; (...); Verdoia, Monica

Article. 10.1016/j.numecd.2024.09.031. 2024

Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry.

Article. 10.1016/j.recesp.2020.02.018. 2020

Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry.

De Luca G; (...); Verdoia M

Article. 10.1097/HJH.0000000000003890. 2024

Impact of intrapatient blood level variability of calcineurin inhibitors on heart transplant outcomes.

González-Vílchez F; (...); Vázquez de Prada JA

Article. 10.1016/j.rec.2021.02.001. 2021

Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.

Article. 10.1002/ehf2.13753. 2022

Impact of left ventricular unloading on postheart transplantation outcomes in patients bridged with VA-ECMO.

Enríquez-Vázquez D; (...); Crespo-Leiro MG

Article. 10.1016/j.rec.2024.09.005. 2024

Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1038/tpj.2017.19. 2018

Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1097/FPC.0000000000000286. 2017

Impact of pre-admission physical activity on benefits of physiology-guided complete revascularization in older patients with myocardial infarction: insights from the FIRE trial.

Pavasini R; (...); Biscaglia S

Article. 10.1093/eurjpc/zwae069. 2024

Impact of preoperative left ventricular unloading on post-transplant outcomes of candidates bridged with venoarterial extracorporeal membrane oxygenation

Enriquez Vazquez, D.; (...); Crespo-Leiro, M.

Meeting Abstract. 2024

Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

De Luca, Giuseppe; (...); Vavlukis, Marija

Article. 10.1016/j.atherosclerosis.2021.06.926. 2021

Impact of serum levels variability of calcineurin inhibitors on heart transplant outcomes

Gonzalez-Vilchez, FJFJ; (...); De Prada, JAV

Meeting Abstract. 2019

Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS-STEMI COVID-19 Registry

De Luca G; (...); Verdoia M

Article. 10.3390/jcm11226722. 2022

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020

Impact of the use of plaque modification techniques on coronary microcirculation using an angiography-derived index of microcirculatory resistance.

Teira Calderon, Andrea; (...); Garcia-Garcia, Hector M

Article. 10.1007/s10554-024-03152-5. 2024

Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019

Impact on Survival of Heart and Heart-Lung Transplantation in Patients With Cyanotic and Noncyanotic Congenital Heart Diseases.

Donoso-Trenado, Victor; (...); Almenar-bonet, Luis

Article. 10.1016/j.transproceed.2024.12.005. 2024

Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020

Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1159/000478969. 2018

Implications of Molecular Markers in Brain-Dead Donors in Primary Graft Dysfunction and Rejection After Heart Transplantation: The Potential Role of Preconditioning

Herrador-Galindo, L.; (...); Moreno-Gonzalez, G.

Meeting Abstract. 10.1016/j.healun.2024.02.526. 2024

Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial.

Santas E; (...); Núñez J

Article. 10.1002/ehf2.14630. 2023

Improving diuresis and dropsy with elamipretide in advanced heart failure (IDDEA-HF); a multi-centre, double-blind, placebo-controlled trial

Cleland, JGF; (...); Pitt, B

Meeting Abstract. 2019

Incidence and factors related to vasoplegia in the early postoperatory period of orthotopic heart transplantation

Meeting Abstract. 2018

Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.

Rodríguez-Veiga R; (...); Sanz GF

Article. 10.1007/s00277-019-03744-5. 2019

Incidence and Prognosis of Colorectal Cancer After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumor Registry

Sagastagoitia-Fornie, Marta; (...); Crespo-Leiro, Maria G.

Article. 10.3389/ti.2023.11042. 2023

Incidence and prognostic impact of adverse clinical events associated to mechanical circulatory support in patients bridged to transplantation on temporary devices: a nationwide Spanish registry.

Caballero, EEB; (...); Hervas-Sotomayor, D

Meeting Abstract. 2017

Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.

García-Ortega A; (...); Martínez-García MÁ

Article. 10.1016/j.jinf.2021.01.003. 2021

Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Vericat, JEM; (...); Bonanad, S

Meeting Abstract. 2018

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago

Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016

Infectious complications associated with short-term mechanical circulatory support in urgent heart transplant candidates.

Solla-Buceta M; (...); Barge-Caballero E

Article. 10.1016/j.rec.2020.11.019. 2021

Infective endocarditis in patients with heart transplantation.

Martínez-Sellés M; (...); Muñoz P

Article. 10.1016/j.ijcard.2020.12.018. 2021

Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019

Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2017.1323267. 2017

Influence of Gender in Advanced Heart Failure Therapies and Outcome Following Transplantation.

García-Cosío MD; (...); Delgado JF

Article. 10.3389/fcvm.2021.630113. 2021

Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.

Ruiz J; (...); Poveda JL

Article. 10.23736/S0026-4946.18.04978-2. 2018

Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021

Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction.

Esteban-Fernández A; (...); Ridocci-Soriano F

Article. 10.1007/s00392-023-02241-0. 2024

Influence of the type of circulatory/ventricular assistance in the primary graft failure and heart transplantation mortality

Meeting Abstract. 2018

Influence on kinesiophobia by disability, physical, and behavioural variables after a heart transplantation.

Marques-Sule E; (...); Bäck M

Article. 10.1093/eurjcn/zvab134. 2022

Intermittent administration of levosimendan ambulatory in patients with advanced chronic heart failure: experience in our center

Martin, PA; (...); Bonet, LA

Meeting Abstract. 2018

Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019

Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020

Iron deficiency and short-term adverse events in patients with decompensated heart failure.

Palau P; (...); Núñez J

Article. 10.1007/s00392-021-01832-z. 2021

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?

Lopez-Vilella, Raquel; (...); Almenar Bonet L

Article. 10.3390/life13040915. 2023

Is the benefit of treating iron deficiency greater in acute heart failure with renal dysfunction?

Lopez Vilella, R. Raquel; (...); Bonet, L. Almenar

Meeting Abstract. 2023

Is there a variation of CA-125 levels with changes in glomerular filtration rate in patients with heart failure?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Is there changes in the diuretic response to hypertonic saline plus furosemide depending on the type of heart failure?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024

Kinesiophobia and associated variables in patients with heart failure.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1093/eurjcn/zvad072. 2023

Kinesiophobia in heart transplantation patients: a cross-sectional study with a special focus in sex differences

Moreno Segura, N.; (...); Marques-Sule, E.

Meeting Abstract. 2023

Kinesiophobia, physical activity and quality of life in patients with heart failure: a cross-sectional study

Sempere-Rubio, N.; (...); Marques-Sule, E.

Meeting Abstract. 2022

Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19

Bekki, Amina; (...); Angel Martinez-Garcia, Miguel

Meeting Abstract. 10.1183/13993003.congress-2021.OA2597. 2021

Left ventricular myocardial dysfunction in arrhythmogenic cardiomyopathy with left ventricular involvement: A door to improving diagnosis

Vives-Gilabert, Y; (...); Zorio, E

Article. 10.1016/j.ijcard.2018.09.024. 2019

Long-term changes in left ventricular ejection fraction depending on the type of heart failure

Meeting Abstract. 2018

Long-term study of prevalence and evolution of tricuspid regurgitation after orthotopic heart transplantation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Malignancy after Heart Transplantation: Difference in incidence and prognosis between genders. Data from the Spanish post-Heart Transplant Tumor Registry

Minguito Carazo, C.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2019

Malignancy following Heart Transplantation: Differences in Incidence and Prognosis between Sexes.

Minguito-Carazo C; (...); Crespo-Leiro MG

Article. 10.1111/tri.13827. 2021

Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

Aguado, JM; (...); Spanish Network for Research in Infectious Diseases (REIPI) (RD16

Article. 10.1016/j.trre.2017.07.001. 2018

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022

Massive Primary Mitral Regurgitation Due to Chordae Rupture: Treatment With New-Generation Edge-to-Edge Repair Devices.

Vilchez-Tschischke JP; (...); Diez-Gil JL

Editorial Material. 10.1016/j.jcin.2020.12.026. 2021

Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021

Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation.

Olivella, Aleix; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.healun.2023.03.008. 2023

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022

Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020

Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure.

Ezzitouny, M.; (...); Martinez-Dolz, L.

Article. 10.1016/j.transproceed.2018.12.013. 2019

Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021

Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.

Fernandez-Megia, MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.10793. 2018

Mortality after the first hospital admission for acute heart failure de novo vs. acutely decompensated heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2023

Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction.

Article. 10.1016/j.amjcard.2023.03.008. 2023

Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021

Musculoskeletal disorders in men and women with heart transplantation. A cross-sectional study

Segura, N. Moreno; (...); Marques-Sule, E.

Meeting Abstract. 2023

Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry.

Salinas P; (...); Escaned J

Article. 10.1002/ccd.30804. 2023

National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter Study

Cassado-Valls, Paula; (...); Comin-Colet, Josep

Article. 10.3390/jcm13247558. 2024

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial.

Núñez J; (...); Bayés-Genís A

Article. 10.1161/JAHA.119.014254. 2020

Noninvasive Liver Assessment in Adult Patients With Fontan Circulation Using Acoustic Radiation Force Impulse Elastography and Hepatic Magnetic Resonance Imaging.

Buendia-Fuentes, F; (...); Martinez-Dolz, L

Article. 10.1177/2150135117732674. 2018

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

One and Six Month OCT Follow up Among Drug Eluting Stents With Persistent, Bioresorbable or Without Polymer. The HORSEPOWER Multicenter and Prospective Study

Tizon-Marcos, Helena; (...); Vaquerizo, Beatriz

Meeting Abstract. 2018

Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Poveda, JL

Meeting Abstract. 2018

OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022

Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy

Esteban Fernandez, A. Alberto; (...); De Juan Baguda, J.

Meeting Abstract. 2024

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

Percutaneous biventricular mechanical assistance as a bridge to heart transplant.

Perez-Guillen, Manuel; (...); Martinez-Leon, Juan B

Case Reports. 10.1016/j.rec.2023.07.007. 2023

Percutaneous Mitral Valve Repair: Outcome Improvement with Operator Experience and a Second-Generation Device.

Freixa X; (...); Arzamendi D

Article. 10.3390/jcm10040734. 2021

Peripheral access ultrafiltration as a treatment for cardiorenal syndrome with inadequate diuretic response. Initial experience

Letter. 10.1016/j.recesp.2022.04.017. 2023

Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.2174/1389200218666171101124931. 2018

Pharmacological Considerations during Percutaneous Treatment of Heart Failure.

Sorolla-Romero JA; (...); Sanz-Sanchez j

Article. 10.2174/0113816128284131240209113009. 2024

Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021

Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022

Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

Calleja Hernández MÁ; (...); Aragon, B

Article. 10.7399/fh.2017.41.1.10463. 2017

Physical activity enjoyment, exercise motivation, and physical activity in patients with heart failure: A mediation analysis.

Klompstra L; (...); Marques-Sule E

Article. 10.1177/02692155221103696. 2022

Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)

Querol-Fuentes, F; (...); Bonanad, S

Meeting Abstract. 2017

Physical activity readiness in patients with heart failure

Klompstra, L; (...); Almenar, L

Meeting Abstract. 2020

Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial.

Biscaglia S; (...); Campo G

Article. 10.1016/j.ahj.2020.08.007. 2020

Pilot evaluation of home delivery programme in haemophilia

Megias-Vericat, JE; (...); Poveda-Andres, JL

Article. 10.1111/jcpt.12718. 2018

PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020

Plaque modification and impact on the microcirculation territory after drug-coated balloon angioplasty. The PLAMI study design

Romero, Jose Antonio Sorolla; (...); Sanchez, Jorge Sanz

Article. 10.24875/RECIC.M23000438. 2024

Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.

Lozano-Edo S; (...); Martínez-Dolz L

Article. 10.1097/TP.0000000000003798. 2021

Polymer Conjugation of Docosahexaenoic Acid Potentiates Cardioprotective Therapy in Preclinical Models of Myocardial Ischemia/Reperfusion Injury.

Tejedor S; (...); Vicent MJ

Article. 10.1002/adhm.202002121. 2021

Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.

Romero S; (...); Sanz J

Article. 10.1080/10428194.2018.1474462. 2019

Practical Requirements for the Development of an Advanced Cardiorenal Unit

Almenar-Bonet, Luis; (...); Sanchez-Perez, Pilar

Review. 10.1159/000536104. 2024

Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process

Valero, S; (...); Poveda, JL

Article. 10.1016/j.yrtph.2018.03.001. 2018

Predicting Sarcopenia and Frailty Risk in Patients Post Heart Transplantation.

Sentandreu-Mano, Trinidad; (...); Machado, Felipe V C

Article. 10.1111/ctr.70027. 2025

PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019

Preliminary experience on the usefulness of immunoglobulin A as a biomarker in patients with decompensated heart failure

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2021

Preoperative Toxoplasma gondii serostatus does not affect long-term survival of cardiac transplant recipients. Analysis of the Spanish Heart Transplantation Registry

Barge-Caballero, E; (...); Gonzalez-Vilchez, F

Article. 10.1016/j.ijcard.2017.09.215. 2018

Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021

Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021

Presence and evolution of multiple pulmonary nodules with halo sign detected by computerized tomography in advanced heart failure

Meeting Abstract. 2018

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study

Helmy, R; (...); BRIGHT Study Team

Article. 10.1016/j.clinthera.2018.11.007. 2019

Prevalence of Tricuspid Regurgitation After Orthotopic Heart Transplantation and Its Evolution in the Follow-up Period: A Long-Term Study.

Article. 10.1016/j.transproceed.2022.09.009. 2022

Prevalence, characteristics, and phenotype associated with tachycardiomyopathy in a cohort of patients first hospitalized for heart failure with reduced ejection fraction

Otero Garcia, O.; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 2024

Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients.

Couto-Mallón D; (...); Crespo-Leiro MG

Article. 10.1016/j.jacc.2023.06.016. 2023

Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics.

Delgado-Jimenez, Juan F.; (...); Crespo-Leiro, Maria G.

Article. 10.3390/jcm11051170. 2022

Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021

Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis.

Urbistondo, Francisco Gonzalez; (...); De Prada, Jose Antonio Vazquez

Article. 10.1016/j.rec.2023.10.006. 2023

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. COMFE registry

Vega, D. Garcia; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.1187. 2024

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. implications for their clinical management. COMFE registry

Garcia Vega, D. David; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.1187. 2024

Prognostic impact of vasopressor test in transcatheter edge-to-edge repair of secondary mitral regurgitation: The PETIT study.

Gonzalez-Gutierrez, Jose Carlos; (...); Amat-Santos, Ignacio J

Article. 10.1002/ccd.31115. 2024

Prognostic implications of hypo and hyperkalaemia in acute heart failure with reduced ejection fraction. Analysis of cardiovascular mortality and hospital readmissions.

Laymito-Quispe RDP; (...); Almenar-Bonet, Luis

Article. 10.1016/j.medcli.2021.03.037. 2022

Prognostic Role of TAPSE to PASP Ratio in Patients Undergoing MitraClip Procedure

Trejo-Velasco, B; (...); Cruz-Gonzalez, I

Article. 10.3390/jcm10051006. 2021

Prognostic value and clinical predictors of intramyocardial hemorrhage measured by CMR T2* sequences in STEMI.

Ferré-Vallverdú M; (...); Igual-Muñoz B

Article. 10.1007/s10554-020-02142-7. 2021

Prognostic Value of Serum Lactate Levels in Patients Undergoing Urgent Heart Transplant: A Subanalysis of the ASIS-TC Spanish Multicenter Study

Couto-Mallon, D; (...); Barge-Caballero, E

Article. 10.1016/j.rec.2018.02.021. 2019

Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler

Letter. 10.1097/DSS.0000000000001046. 2017

Pulmonary venous thrombosis secondary to radiofrequency ablation of the pulmonary veins.

Lopez-Reyes, R; (...); Nauffal, D

Article. 10.1016/j.rmcr.2017.11.008. 2018

QFR for the Revascularization of Nonculprit Vessels in MI Patients Insights From the FIRE Trial

Erriquez, Andrea; (...); Biscaglia, Simone

Article. 10.1016/j.jcin.2024.04.022. 2024

Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker

Perez-Alenda, S; (...); Querol, F

Letter. 10.1111/hae.13388. 2018

Rationale and Design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.

Amat-Santos IJ; (...); Raposeiras-Roubín S

Article. 10.1002/ejhf.2370. 2021

Real world comparison of spironolactone and eplerenone in patients with heart failure.

Pardo-Martinez, Patricia; (...); Crespo-Leiro, Maria G

Article. 10.1016/j.ejim.2021.12.027. 2022

Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.

Cuéllar Monreal MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.2017.41.1.10434. 2017

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.

Ufnal, Marcin; (...); Rosenkranz, Stephan

Article. 10.1002/ehf2.15203. 2025

Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic.

De Luca G; (...); Verdoia M

Article. 10.1016/j.deman.2021.100022. 2021

Repetitive ambulatory doses of levosimendan as a bridge to heart transplant: patients characteristics and prescription patterns from the LEVO-T Registry.

De Juan Baguda, J.; (...); Gonzalez Costello, J.

Meeting Abstract. 2022

Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.

De Juan Baguda, J. Javier; (...); Gonzalez-Costello, J.

Meeting Abstract. 2022

Repetitive ambulatory levosimendan as a bridge to heart transplantation.

Baguda, Javier De Juan; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2023.07.002. 2023

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry

Salterain-Gonzalez, Nahikari; (...); Gonzalez-Vilchez, Francisco

Article. 10.1016/j.recesp.2021.06.010. 2022

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry.

Salterain-Gonzalez, Nahikari; (...); Gonzalez-Vilchez, Francisco

Article. 10.1016/j.rec.2021.06.009. 2021

Revascularization of Donor Transmitted Coronary Artery Disease After Heart Transplantation: Impact on Survival and Cardiovascular Events. Insights from the DONOR-CAD Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2023

Reversal of anticoagulation with idarucizumab. Initial experience in heart and heart-and-lung transplantation

Vilella, RL; (...); Bonet, LA

Meeting Abstract. 2018

Review of the allocation criteria for heart transplant in Spain in 2023 . SEC-Heart Failure Association/ONT/SECCE consensus document

González-Costello J; (...); Domínguez-Gil B

Review. 10.1016/j.rec.2023.11.001. 2024

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Spyropoulos, AC; (...); MARINER Investigators

Article. 10.1056/NEJMoa1805090. 2018

Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode.

Olivella, Aleix; (...); Facila Rubio, Lorenzo

Article. 10.1002/ehf2.14647. 2023

Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial.

Chiarito, Mauro; (...); Stefanini, Giulio

Article. 10.1186/s12933-023-01744-4. 2023

Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.

Sole, A; (...); Peman, J

Article. 10.1111/ajt.14580. 2018

SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020

Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

Aguas Peris M; (...); Nos, P

Article. 10.1097/MIB.0000000000001182. 2017

Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice

Aguas, M; (...); Nos, P

Meeting Abstract. 2017

Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry

Ambrosio, Giuseppe; (...); Maggioni, Aldo P.

Article. 10.1016/j.ejim.2021.04.001. 2021

Severity of Donor Transmitted Coronary Artery Disease and Survival after Heart Transplantation. Results from the Donor Coronary Artery Disease (DONOR-CAD) Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2023

Sex, Temporary Mechanical Circulatory Support, and HeartTransplantation: Insights From a Multi-Institutional SpanishRegistry.

Enriquez-Vazquez, Daniel; (...); Crespo-Leiro, Maria G.

Letter. 10.1016/j.jchf.2023.07.027. 2023

Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial.

Santas E; (...); Núñez J

Article. 10.1002/ehf2.13053. 2020

Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial.

Del Canto I; (...); Núñez J

Article. 10.1161/JAHA.121.022214. 2022

Short-term changes in left and right ventricular CMR feature tracking strain following ferric carboxymaltose in patients with heart failure: a substudy of the Myocardial-IRON trial

Del Canto Serrano, I.; (...); Nunez, J. V.

Meeting Abstract. 2021

Similar degree of intimal coverage and apposition among drug-eluting stents with persistent, absorbable or without polymer at 1 and 6 months after implantation

Fernandez, AC; (...); Vaquerizo, B

Meeting Abstract. 2020

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Otero Garcia, O. Oscar; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.836. 2024

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.836. 2024

SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022

Sodium-glucose cotransporter 2 inhibitors reduce cardiovascular events in acute heart failure. A real-world analysis.

Article. 10.1016/j.ejim.2022.06.008. 2022

Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022).

Jurado-Román A; (...); García de la Borbolla Fernández R

Article. 10.1016/j.rec.2023.07.012. 2023

Spanish Heart Transplant Registry. 28th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2016)

Gonzalez-Vilchez, F; (...); Spanish Heart Transplant Teams

Article. 10.1016/j.recesp.2017.07.032. 2017

Spanish Heart Transplant Registry. 29th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure

Gonzalez-Vilchez, F; (...); Representation Equipos Espanoles T

Article. 10.1016/j.recesp.2018.07.020. 2018

Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)

Gonzalez-Vilchez, F; (...); Abella-Anton, R

Article. 10.1016/j.rec.2019.09.005. 2019

Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology

Gonzalez-Vilchez, F; (...); Casasnovas, IS

Article. 10.1016/j.recesp.2020.06.024. 2020

Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vilchez F; (...); Groba Marco MDV

Article. 10.1016/j.rec.2020.06.035. 2020

Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

Gonzalez-Vilchez, Francisco; (...); Jesus Valero-Masa, Maria

Article. 10.1016/j.recesp.2021.06.012. 2021

Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology.

Gonzalez-Vilchez, Francisco; (...); Valero-Masa, Maria Jesus

Article. 10.1016/j.rec.2021.08.001. 2021

Spanish heart transplant registry. 33rd official report of the Heart failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2022.06.011. 2022

Spanish heart transplant registry. 34th official report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2023.06.013. 2023

Spanish heart transplant registry. 35th official report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2024.05.015. 2024

Spanish multicenter study on the monitoring and incidence of hyperkalaemia in patients with heart failure and reduced ejection fraction. SPANIK-HF

Crespo-Leiro, M.; (...); Delgado-Jimenez, J. F.

Meeting Abstract. 2022

Specific test panels for patients with heart failure: implementation and use in the Spanish National Health System

Almenar Bonet, Luis; (...); Generosa Crespo-Leiro, Andmaria

Article. 10.1515/almed-2022-0006. 2022

Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R)

Sinning, Christoph; (...); Kirchhof, Paulus

Article. 10.1002/ehf2.13574. 2021

Study of molecules involved in cellular traffic in advanced heart failure: are there differences in the nivels of these molecules between ischemic heart disease and idiopathic dilated cardiomyopathy?

Ezzitouny, M.; (...); Martinez-Dolz, L.

Meeting Abstract. 2018

Supervised Domain Adaptation for Automated Semantic Segmentation of the Atrial Cavity

Saiz-Vivo, Marta; (...); Naranjo, Valery

Article. 10.3390/e23070898. 2021

Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis

Amat-Santos, Ignacio J.; (...); Roman, J. Alberto San

Article. 10.1016/j.jcin.2024.09.003. 2024

Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022

Technology usage, interest and preferences about technology-based cardiac rehabilitation programmes in heart failure

Sempere-Rubio, N.; (...); Marques-Sule, E.

Meeting Abstract. 2022

Technology Usage, Physical Activity, and Motivation in Patients With Heart Failure and Heart Transplantation.

Deka P; (...); Marques-Sule E

Article. 10.1097/CIN.0000000000001049. 2023

Temporal trend and potential impact of angiotensin receptor neprilysin inhibitors on transcatheter edge-to-edge mitral valve repair.

Barrero, Alejandro; (...); Spanish TEER Group

Article. 10.1016/j.rec.2022.02.001. 2022

Temporal trends in the use and outcomes of temporary mechanical circulatory support as a bridge to cardiac transplantation in Spain. Final report of the ASIS-TC study.

Barge-Caballero, Eduardo; (...); Crespo-Leiro, Maria G.

Article. 10.1016/j.healun.2022.10.020. 2022

The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity

Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar

Article. 10.1007/s00431-022-04628-z. 2022

The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Gil-Nagel A; (...); Gil A

Article. 10.1016/j.yebeh.2022.108711. 2022

The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions.

Article. 10.3389/fcvm.2021.618398. 2021

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024

The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus

Torrent-Farnell, J; (...); Lizan, L

Article. 10.1016/j.healthpol.2018.03.002. 2018

Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2023

Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment.

Article. 10.1002/ehf2.14386. 2023

Three cases of psychosis after use of sacubitril/valsartan.

Perez-Rosello, Victor; (...); Almenar-Bonet, Luis

Letter. 10.1016/j.recesp.2020.05.019. 2021

Thrombocytopenia after transcatheter aortic valve implantation.

Tirado-Conte G; (...); Nombela-Franco L

Article. 10.1016/j.rec.2024.08.003. 2024

Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020

Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024

Toxoplasma gondii serostatus is not an independent predictor of survival in heart transplant recipients: analysis of the Spanish Heart Transplant Registry

Caballero, EEB; (...); Blasco-Peiro, T

Meeting Abstract. 2017

Transcatheter mitral repair according to the cause of mitral regurgitation: real-life data from the Spanish MitraClip registry

Pascual, Isaac; (...); Estevez-Loureiro, Rodrigo

Article. 10.1016/j.recesp.2019.07.014. 2020

Transcatheter mitral repair according to the cause of mitral regurgitation: Real-life data from the Spanish MitraClip registry.

Pascual I; (...); Estévez-Loureiro R

Article. 10.1016/j.rec.2019.07.018. 2019

Transcatheter Mitral Repair for Functional Mitral Regurgitation According to Left Ventricular Function: A Real-Life Propensity-Score Matched Study

Pascual, I; (...); Estevez-Loureiro, R

Article. 10.3390/jcm9061792. 2020

Transient pulmonary nodules with halo sign in patients with advanced heart failure: a report of two cases.

López-Vilella R; (...); Bonet LA

Article. 10.1016/j.clinimag.2019.11.008. 2020

Ultrafiltracion de acceso periferico como tratamiento del sindrome cardiorrenal con insuficiente respuesta diuretica. Experiencia inicial.

Art Exhibit Review. 10.1016/j.rec.2022.04.013. 2022

Uncontrolled asistole donation. Impact on primary graft failure and heart transplantation survival

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

Bejar, S; (...); Mateu, PN

Meeting Abstract. 2020

Unveiling the prognostic journey: renal function trajectories in 'de novo' heart failure with reduced ejection fraction - insights from a cohort study and their impact on patient outcomes

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.835. 2024

Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy

Garcia, SV; (...); Andres, JLP

Article. 10.1016/j.yrtph.2018.10.002. 2018

Use of a surgically implanted, extracorporeal continuous flow circulatory support system as a bridge to heart transplantation

Cabezon Villalba, G. Gonzalo; (...); Crespo-Leiro, M. G. C. L.

Meeting Abstract. 2023

Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant.

Villalba, Gonzalo Cabezon; (...); Crespo-Leiro, Maria G

Article. 10.1016/j.rec.2023.05.002. 2024

USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Dominguez Hernandez, L.; (...); Gomez Segui, I

Meeting Abstract. 2019

Use of cutting or scoring balloons in patients with native coronary artery disease: systematic review and meta-analysis

Romero, Jose Antonio Sorolla; (...); Sanchez, Jorge Sanz

Letter. https://doi.org/10.24875/RECICE.M24000448. 2024

Use of idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. a multicentric experience in spain

Crespo-Leiro, MGMG; (...); Almenar-Bonet, L

Meeting Abstract. 2019

Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain.

Crespo-Leiro MG; (...); Almenar-Bonet L

Article. 10.1111/ctr.13748. 2019

Use of Intra-aortic Balloon Pump as a Bridge to Heart Transplant in Spain: Results From the ASIS-TC Study.

Barge-Caballero, E; (...); Crespo-Leiro, MG

Article. 10.1016/j.rec.2018.07.003. 2019

Usefulness of biomarkers to predict prognosis after heart transplant

Lopez-Vilella, Raquel; (...); Boneta, Luis Almenar

Article. 10.1016/j.rec.2024.04.019. 2024

Usefulness of Immunoglobulin A in Patients With Decompensated Heart Failure: Is It a Future Marker of Congestion? Preliminary Experience.

Article. 10.1016/j.transproceed.2021.07.051. 2021

Usefulness of short-term peripheral ambulatory ultrafiltration in heart failure refractory to diuretics. Initial experience.

Guerrero Cervera B; (...); Almenar Bonet L

Article. 10.1016/j.medcli.2023.04.008. 2023

Usefulness of the biomarker CA125 in the diagnosis of acute cellular rejection in allogeneic heart transplantation

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019

Utility of nucleocytoplasmic transport as a marker in critical heart failure with circulatory assistance as a bridge to transplant

Ezzitouny, M.; (...); Marinez-Dolz, L.

Meeting Abstract. 2020

Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.07.058. 2021

Utility of the IMPACT score for predicting heart transplant mortality. Analysis on a contemporary cohort of the Spanish Heart Transplant Registry

Ortiz-Bautista, Carlos; (...); Delgado-Jimenez, Juan F.

Article. 10.1111/ctr.14774. 2022

Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination.

Pastor Pueyo, Pablo; (...); Worner Diz, Fernando

Article. 10.1007/s00392-023-02225-0. 2023

Validation of miR-181A-5p as a biomarker of acute rejection after heart transplantation. Multicenter study

Crespo-Leiro, M.; (...); Domenech-Garcia, N.

Meeting Abstract. 2023

Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter study.

Goirigolzarri Artaza, Josebe; (...); Segovia Cubero, Javier

Article. 10.1016/j.recesp.2020.01.033. 2020

VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023

Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support.

Ezzitouny M; (...); Martínez-Dolz L

Article. 10.3390/jpm11111122. 2021

Variation in diuretic requirement after peripheral ultrafiltration in heart failure with diuretic resistance

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Variations in the medical treatment of heart failure during admission for decompensation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Venoarterial extracorporeal membrane oxygenation with or without simultaneous intra-aortic balloon pump support as a direct bridge to heart transplantation: results from a nationwide Spanish registry.

Barge-Caballero G; (...); Barge-Caballero E

Article. 10.1093/icvts/ivz155. 2019

Well-Being, Physical Activity, and Social Support in Octogenarians with Heart Failure during COVID-19 Confinement: A Mixed-Methods Study

Marques-Sule, Elena; (...); Luis Cabanillas-Garcia, Juan

Article. 10.3390/ijerph192215316. 2022

What clinical parameters are associated with the prescription at hospital discharge of all medications with prognostic improvement? Analysis in de novo heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Bonet, Almenar

Meeting Abstract. 2024

What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction

Donoso Trenado, V.; (...); Almenar-Bonet, L.

Meeting Abstract. 2024

What motivates heart transplantation patients to exercise and engage in physical activity? A network analysis.

Marques-Sule, Elena; (...); Machado, Felipe V C

Article. 10.1093/eurjcn/zvad051. 2023

Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study.